Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation

Table 4

Univariate and multivariate Cox regression analysis of major adverse cardiovascular events.

Variables	Univariate analysis RR (95% CI)		Multivariate analysis RR (95% CI)
Age	1.072 (1.040–1.106)	0.000	1.041 (1.008–1.074)	0.013
Male	1.002 (0.587–1.709)	0.994
CCSA > II	1.762 (1.137–2.730)	0.011	1.009 (0.563–1.808)	0.874
LVEF < 50%	1.662 (1.069–2.585)	0.024	1.061 (0.591–1.906)	0.842
Diabetes mellitus	1.760 (1.053–2.940)	0.031	1.234 (0.677–2.250)	0.493
Hypertension	1.125 (0.725–1.744)	0.599
Hyperlipidemia	1.096 (0.694–1.731)	0.693
Current smoking	1.254 (0.797–1.973)	0.327
PTX3	3.233 (1.968–5.311)	0.000	2.512 (1.466–4.305)	0.001
cTnI	1.029 (1.011–1.047)	0.002	1.012 (1.004–1.284)	0.008
HsCRP	1.832 (1.529–2.195)	0.000	1.093 (0.998–1.197)	0.056
Multiple stents	2.694 (1.724–4.211)	0.000	2.401 (1.479–3.899)	0.0004

Abbreviations as in Table 1.